WaveForm Diabetes (formerly AgaMatrix Holdings) Revenue and Competitors

Salem, NH USA

Location

$152.2M

Total Funding

Estimated Revenue & Valuation

  • WaveForm Diabetes (formerly AgaMatrix Holdings)'s estimated annual revenue is currently $30.6M per year.(i)
  • WaveForm Diabetes (formerly AgaMatrix Holdings)'s estimated revenue per employee is $251,000
  • WaveForm Diabetes (formerly AgaMatrix Holdings)'s total funding is $152.2M.

Employee Data

  • WaveForm Diabetes (formerly AgaMatrix Holdings) has 122 Employees.(i)
  • WaveForm Diabetes (formerly AgaMatrix Holdings) grew their employee count by 0% last year.

WaveForm Diabetes (formerly AgaMatrix Holdings)'s People

NameTitleEmail/Phone
1
President and CEOReveal Email/Phone
2
VP EngineeringReveal Email/Phone
3
VP Human ResourcesReveal Email/Phone
4
VP, Quality Assurance, Regulatory and Clinical AffairsReveal Email/Phone
5
Director Scientific DevelopmentReveal Email/Phone
6
DirectorReveal Email/Phone
7
Manager Financial Planning & AnalysisReveal Email/Phone
8
Diabetes Care ManagerReveal Email/Phone
9
Manager, iOS DevelopmentReveal Email/Phone
10
Diabetes Care ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$15.3M109-42%$106.2MN/A
Add Company

What Is WaveForm Diabetes (formerly AgaMatrix Holdings)?

AgaMatrixÔ is a consumer medical device company headquartered in Salem, New Hampshire that develops and manufactures next generation blood glucose monitoring products for the diabetes market. The Company\'s proprietary WaveSenseÔ platform, a suite of biosensor and Dynamic ElectrochemicalÔ technologies, enables high accuracy glucose sensing. Current products include a meter and strip system; future products include a cartridge-based system that fully integrates lancets and sensors.

keywords:N/A

$152.2M

Total Funding

122

Number of Employees

$30.6M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

WaveForm Diabetes (formerly AgaMatrix Holdings) News

2019-07-08 - AgaMatrix raises $56M to develop and sell its WaveForm CGM

The diabetes diagnostic-focused AgaMatrix has secured a capital raise of about $56 million, with plans to support clinical trials of a continuous glucose monitoring system being developed under its WaveForm Technologies subsidiary. Sponsored by Agilent Technologies How would you like to win fr ...

2012-12-31 - Misfit Wearables Puts Design First in New Activity Tracker

Share Share on Facebook Share on Twitter LinkedIn Email Reprints Misfit Wearables cofounder and CEO Sonny Vu learned a valuable lesson at his last company, AgaMatrix. The mobile health startup produced a blood glucose meter called the iBGStar, which allows users to check, monitor and share thei ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$40.3M1225%N/A
#2
$33.2M123-2%N/A
#3
$19.1M12310%N/A
#4
$34M12612%N/A
#5
$41.9M1276%N/A